NCT05087355

Brief Summary

The overall project aim is to study outcomes after COVID-19 and influenza hospitalisation from 2016 - 2021 by retrieving data from the main social security carriers in Austria for the years 2010-2018

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
440,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2016

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
5.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 19, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 21, 2021

Completed
Last Updated

October 29, 2021

Status Verified

October 1, 2021

Enrollment Period

5.7 years

First QC Date

October 19, 2021

Last Update Submit

October 22, 2021

Conditions

Covid 19Influenza

Outcome Measures

Primary Outcomes (6)

  • Overall Mortality

    Overall mortality after influenza or covid-19

    5 years

  • age distribution

    age distribution in patients with influenza or covid-19

    5 years

  • risk profile

    risk profile (e.g. prior diseases, medication) in patients who died due to influenza or covid-19

    5 years

  • newly diagnosed diseases

    newly diagnosed diseases after influenza or covid-19

    5 years

  • newly prescribed medication

    newly prescribed medication after influenza or covid-19

    5 years

  • duration of hospitalisation or unemployability

    duration of hospitalisation or unemployability after influenza or covid-19

    5 years

Study Arms (3)

Influenza

Diagnostic Test: PCR or antigen test for Covid 19 or Inluenza

Covid 19

Diagnostic Test: PCR or antigen test for Covid 19 or Inluenza

Control group

hospitalisation due to other disease (not influenza or Covid 19)

Diagnostic Test: PCR or antigen test for Covid 19 or Inluenza

Interventions

PCR or antigen test for Covid 19 or InluenzaDIAGNOSTIC_TEST

PCR or antigen test for Covid 19 or Inluenza

Control groupCovid 19Influenza

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients with or after Covid-19 or influenza between 2016-2021 in Austria will be included in this study

You may qualify if:

  • Patients with SARS
  • Patients with Covid-19
  • Patients after Covid-19
  • Patients with influenza

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

COVID-19Influenza, Human

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesOrthomyxoviridae Infections

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator/Univ. Prof. , MD, MBA

Study Record Dates

First Submitted

October 19, 2021

First Posted

October 21, 2021

Study Start

January 1, 2016

Primary Completion

August 31, 2021

Study Completion

August 31, 2021

Last Updated

October 29, 2021

Record last verified: 2021-10